Clinical trial study on the therapeutic effect of Tenofovir besides routine drug regime (standard of care) in patients with Coronavirus disease 2019 (COVID-19)
Phase 2
- Conditions
- covid-19.Covid-19, confirmed cases, positive test resultU07.1
- Registration Number
- IRCT20200422047168N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1- People over 18 years of age,
2- Real-time PCR positive test result for SARS-CoV-2 virus was positive after sampling (nasopharynx and oropharynx swab samples).
3. The manifestations of pneumonia caused by the virus in CT scans of their lungs are quite obvious.
4- They have 93% or lower O2 Saturation percentage
Exclusion Criteria
1- History of renal failure,
2- Taking drugs that interfere with Tenofovir
3. Patients who have been admitted to other clinical trials
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduce the mortality rate of patients with Covid-19. Timepoint: days 0-7. Method of measurement: Based on the percentage of discharged Covid-19 patients.
- Secondary Outcome Measures
Name Time Method